CME Grant Disclosures for 2012 to 3rd Quarter of 2013
We have compiled a chart of companies that have disclosed their educational grant payments for 2012-2013. Some companies have disclosure information for several years. Now that grants are subject to Sunshine Act reporting requirements for teaching hospitals, it is likely more companies will begin to post such payments to teaching hospitals. We will add additional information as it becomes available.
Company
2013
2012
2011
2010
2009
Abbott
Q1
Q1
Q1
Q1
Q2
Q2
Q2
Q2
Q3
Q3
Q3
Q3
Q4
Q4
Q4
Allergan
Q1 & Q2
Q1 & Q2
Q1 & Q2
Q3 & Q4
Q3 & Q4
Q3
Amgen
Q1
Q1
Q1
Q1
Q1
Q2
Q2
Q2
Q2
Q2
Q3
Q3
Q3
Q3
Q3
Q4
Q4
Q4
Q4
Astellas Pharma US, Inc.
Q1
Q1
Q1
Q2
Q2
Q2
Q2
Q3
Q3
Q3
Q3
Q4
Q4
Q4
Q4
Astra Zeneca
Q1 & Q2
Q1& Q2
Q1 & Q2
Q1 & Q2
Q1 & Q2
Q3 & Q4
Q3 &Q4
Q3 &Q4
Q3 &Q4
...
Source: Policy and Medicine - Category: Health Medicine and Bioethics Commentators Authors: Thomas Sullivan Source Type: blogs
More News: Allergy | AstraZeneca | Biotechnology | Education | Grants | Health Medicine & Bioethics Commentators | Hospitals | Medical Ethics | Merck | Orthopaedics | Pfizer | Pharmaceuticals | Teaching | Teaching Hospitals | Universities & Medical Training